Target Name: TES
NCBI ID: G26136
Review Report on TES Target / Biomarker Content of Review Report on TES Target / Biomarker
TES
Other Name(s): testin LIM domain protein | Testin | TES variant 1 | TESS-2 | MGC1146 | testis derived transcript (3 LIM domains) | DKFZp586B2022 | Testin (isoform 1) | TESS | Testin LIM domain protein, transcript variant 1 | TES_HUMAN

TES: A Potential Drug Target and Biomarker for LIM Domain-Controlled Proteins

The LIM domain is a family of transmembrane proteins that play a crucial role in various cellular processes. These proteins are involved in a wide range of cellular signaling pathways, including cell adhesion, migration, and intracellular signaling. TES (testin LIM domain) is a protein that belongs to the LIM family and has been identified as a potential drug target and biomarker.

In this article, we will discuss the structure and function of TES, its potential as a drug target, and its potential as a biomarker for various diseases.

Structure and Function of TES

TES is a 21-kDa protein that consists of a unique N-terminal LIM domain and a C-terminal T domain. The LIM domain is a transmembrane protein that is involved in the formation of a long N-terminal tail that can interact with various signaling molecules. The T domain is a unique protein that is involved in the regulation of cellular signaling pathways.

TES is a protein that is expressed in various tissues, including brain, heart, and pancreas. It is also involved in various cellular signaling pathways, including the regulation of cell adhesion, migration, and intracellular signaling. TES has been shown to play a role in the regulation of various signaling pathways, including the regulation of cell growth, differentiation, and survival.

Potential as a Drug Target

TES has been identified as a potential drug target due to its involvement in various cellular signaling pathways. The N-terminal LIM domain of TES is involved in the formation of a long N-terminal tail that can interact with various signaling molecules. This interaction between TES and signaling molecules could make it an attractive target for small molecules that can modulate the activity of TES.

In addition, TES is involved in the regulation of cellular signaling pathways that are important for the development and progression of various diseases, including cancer. The regulation of cellular signaling pathways by TES has been shown to play a role in the development of various diseases, including cancer. Therefore, TES could be an attractive target for small molecules that can modulate the activity of TES and contribute to the development and progression of cancer.

Potential as a Biomarker

TES has also been identified as a potential biomarker for various diseases. The regulation of cellular signaling pathways by TES is involved in the development and progression of various diseases, including cancer. Therefore, TES could be a potential biomarker for the diagnosis and treatment of various diseases.

TES has been shown to be involved in the regulation of cellular signaling pathways that are important for the development and progression of diseases, including cancer. The regulation of cellular signaling pathways by TES has been shown to play a role in the development and progression of various diseases, including cancer. Therefore, TES could be a potential biomarker for the diagnosis and treatment of cancer.

Conclusion

TES is a protein that has been identified as a potential drug target and biomarker for various diseases. Its unique N-terminal LIM domain and C-terminal T domain, as well as its involvement in various cellular signaling pathways, make it an attractive target for small molecules that can modulate its activity. TES has also been identified as a potential biomarker for the diagnosis and treatment of various diseases, including cancer. Further research is needed to determine the role of TES in the development and progression of diseases.

Protein Name: Testin LIM Domain Protein

Functions: Scaffold protein that may play a role in cell adhesion, cell spreading and in the reorganization of the actin cytoskeleton. Plays a role in the regulation of cell proliferation. May act as a tumor suppressor. Inhibits tumor cell growth

The "TES Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TES comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

TESC | TESK1 | TESK2 | TESMIN | TESPA1 | TET1 | TET2 | TET2-AS1 | TET3 | Tetraspanin | TEX10 | TEX101 | TEX11 | TEX12 | TEX13A | TEX13B | TEX13C | TEX14 | TEX15 | TEX19 | TEX2 | TEX21P | TEX22 | TEX26 | TEX261 | TEX264 | TEX28 | TEX29 | TEX30 | TEX33 | TEX35 | TEX36 | TEX36-AS1 | TEX37 | TEX38 | TEX41 | TEX43 | TEX44 | TEX45 | TEX46 | TEX47 | TEX48 | TEX49 | TEX50 | TEX52 | TEX53 | TEX55 | TEX56P | TEX9 | TF | TFAM | TFAMP1 | TFAP2A | TFAP2A-AS1 | TFAP2A-AS2 | TFAP2B | TFAP2C | TFAP2D | TFAP2E | TFAP4 | TFB1M | TFB2M | TFCP2 | TFCP2L1 | TFDP1 | TFDP1P2 | TFDP2 | TFDP3 | TFE3 | TFEB | TFEC | TFF1 | TFF2 | TFF3 | TFG | TFIID Basal Transcription Factor Complex | TFIIIC2 complex | TFIP11 | TFIP11-DT | TFPI | TFPI2 | TFPT | TFR2 | TFRC | TG | TGDS | TGFA | TGFA-IT1 | TGFB1 | TGFB1I1 | TGFB2 | TGFB2-AS1 | TGFB3 | TGFBI | TGFBR1 | TGFBR2 | TGFBR3 | TGFBR3L | TGFBRAP1 | TGIF1